...
首页> 外文期刊>MBio >Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption
【24h】

Phage Resistance in Multidrug-Resistant Klebsiella pneumoniae ST258 Evolves via Diverse Mutations That Culminate in Impaired Adsorption

机译:多药抗性的噬菌体抗性<命名含量含量 - 型=“属型”> Klebsiella肺炎 ST258通过多样化的突变演变,这些突变在受损的吸附中

获取原文
           

摘要

The evolution of phage resistance poses an inevitable threat to the efficacy of phage therapy. The strategic selection of phage combinations that impose high genetic barriers to resistance and/or high compensatory fitness costs may mitigate this threat. However, for such a strategy to be effective, the evolution of phage resistance must be sufficiently constrained to be consistent. In this study, we isolated lytic phages capable of infecting a modified Klebsiella pneumoniae clinical isolate and characterized a total of 57 phage-resistant mutants that evolved from their prolonged coculture in vitro . Single- and double-phage-resistant mutants were isolated from independently evolved replicate cocultures grown in broth or on plates. Among resistant isolates evolved against the same phage under the same conditions, mutations conferring resistance occurred in different genes, yet in each case, the putative functions of these genes clustered around the synthesis or assembly of specific cell surface structures. All resistant mutants demonstrated impaired phage adsorption, providing a strong indication that these cell surface structures functioned as phage receptors. Combinations of phages targeting different host receptors reduced the incidence of resistance, while, conversely, one three-phage cocktail containing two phages targeting the same receptor increased the incidence of resistance (relative to its two-phage, nonredundant receptor-targeting counterpart). Together, these data suggest that laboratory characterization of phage-resistant mutants is a useful tool to help optimize therapeutic phage selection and cocktail design.
机译:噬菌体抗性的演变对噬菌体疗法的疗效构成了不可避免的威胁。对抵抗和/或高补偿性健身成本施加高遗传障碍的噬菌体组合的战略选择可能会减轻这种威胁。然而,对于这种策略有效,噬菌体抗性的演变必须足够约束以保持一致。在这项研究中,我们孤立能够感染改性的克莱布氏菌临床分离物的裂解噬菌体,并表征了总共57个噬菌体抗性突变体,其在体外从其延长的共培养中演变。从肉汤或板上生长的独立演进的复制共培养物中分离出单噬菌体和双噬菌体抗突变体。在相同条件下,抗性分离物在相同的噬菌体中进化,赋予抗性的突变在不同的基因中发生,但在每种情况下,这些基因的推定功能在特定细胞表面结构的合成或组装周围聚集。所有抗性突变体都证明了噬菌体吸附受损,提供了强烈指示,这些细胞表面结构用作噬菌体受体。靶向不同宿主受体的噬菌体的组合降低了抗性的发生率,而相反地,含有靶向同一受体的两个噬菌体的三个噬菌体鸡尾酒增加了抗性的发生率(相对于其两噬菌体,非冗余的受体靶向对应物)增加了抗性的发生率。这些数据表明,抗噬突变体的实验室表征是一种有用的工具,有助于优化治疗噬菌体选择和鸡尾酒设计。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号